We present 25 a streamlined linear cap-independent RNA (LciRNA) cancer vaccine platform that achieves stable 26 expression in vivo without 5’ capping or ribonucleotide modification, and innately stimulates 27 immune responses to enhance antitumor immunity. By fusing a UPA protective sequence, compos...
ORGANISM(S): Homo sapiens (Human)
